Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antidepressant medication usage in the pediatric population.

Clarence Chou

    WMJ : Official Publication of the State Medical Society of Wisconsin
    |December 30, 2004
    PubMed
    Summary

    Untreated pediatric depression poses serious risks. While antidepressants carry risks like suicidal ideation, careful physician-supervised treatment offers benefits outweighing potential harm for children.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Mental health impacts all practices.

    WMJ : official publication of the State Medical Society of Wisconsin·2004
    Same author

    Dealing with the "difficult" patient.

    WMJ : official publication of the State Medical Society of Wisconsin·2004
    See all related articles

    Area of Science:

    • Child and Adolescent Psychiatry
    • Clinical Psychology
    • Pharmacology

    Background:

    • Untreated depression in children presents significant health risks, including potential for worsened outcomes compared to treatment.
    • The use of antidepressant medication in pediatric depression involves a complex balance of documented benefits and potential risks, including increased suicidal thoughts and behaviors.

    Discussion:

    • Physicians must independently verify pediatric depression diagnoses, obtain informed consent from guardians and patients, and meticulously monitor treatment progress.
    • Awareness of potential medication side effects, such as agitation, impulsivity, and suicidal tendencies, is crucial for safe and effective management.
    • The principle that all medications have both benefits and risks, with none being entirely benign, guides clinical decision-making.

    Key Insights:

    • Careful antidepressant use is a component of pediatric depression treatment, despite inherent risks.
    • Risk-benefit analysis necessitates vigilant monitoring and informed consent in pediatric psychopharmacology.
    • The clinical conundrum of pediatric depression treatment highlights the need for individualized, monitored therapeutic approaches.

    Outlook:

    • Continued research into optimizing antidepressant efficacy and safety in pediatric populations is warranted.
    • Enhanced clinical guidelines for managing pediatric depression, focusing on risk stratification and monitoring, are essential.
    • Future strategies may involve integrated care models combining psychotherapy and pharmacotherapy for improved pediatric mental health outcomes.

    Related Experiment Videos